Shanmuga Hospital IPO Overview
Shanmuga Hospital IPO is a fixed price issue of Rs 20.62 crores. The issue is entirely a fresh issue of 38.18 lakh shares.
Shanmuga Hospital IPO opens for subscription on February 13, 2025 and closes on February 17, 2025. The allotment for the Shanmuga Hospital IPO is expected to be finalized on Tuesday, February 18, 2025. Shanmuga Hospital IPO will be list on BSE SME with a tentative listing date fixed as Thursday, February 20, 2025.
Shanmuga Hospital IPO price is ₹54 per share. The minimum lot size for an application is 2000. The minimum amount of investment required by retail investors is ₹1,08,000. The minimum lot size investment for HNI is 2 lots (4,000 shares) amounting to ₹2,16,000.
Finshore Management Services Limited is the book running lead manager of the Shanmuga Hospital IPO, while Integrated Registry Management Services Private Limited is the registrarfor the issue.The market maker for Shanmuga Hospital IPO is Black Fox Financial Private Limited.Refer to Shanmuga Hospital IPO RHP for detailed information.
Shanmuga Hospital IPO Important dates
Shanmuga Hospital IPO opens on February 13, 2025, and closes on February 17, 2025.
IPO Open Date | Thursday, February 13, 2025 |
IPO Close Date | Monday, February 17, 2025 |
Basis of Allotment | Tuesday, February 18, 2025 |
Initiation of Refunds | Wednesday, February 19, 2025 |
Credit of Shares to Demat | Wednesday, February 19, 2025 |
Listing Date | Thursday, February 20, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on February 17, 2025 |
Shanmuga Hospital IPO Financial Performance
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
Assets | 36.53 | 33.92 | 23.05 | 10.65 | ||||||||||||||||||||||||||||||||||||
Revenue | 24.83 | 43.39 | 39.5 | 41.47 | ||||||||||||||||||||||||||||||||||||
Profit After Tax | 3.24 | 5.26 | 4.76 | 6.72 | ||||||||||||||||||||||||||||||||||||
Net Worth | 19.53 | 17.13 | 11.82 | 7.06 | ||||||||||||||||||||||||||||||||||||
Reserves and Surplus | 9.73 | 7.34 | 11.74 | 6.98 | ||||||||||||||||||||||||||||||||||||
Total Borrowing | 9.76 | 9.02 | 7.65 | |||||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
Shanmuga Hospital IPO Key Performance Indicator
The market capitalization of Shanmuga Hospital IPO is Rs 73.51 Cr.
KPI as of Sun, Mar 31, 2024.
KPI | Values |
---|---|
ROE | 30.71% |
ROCE | 35.89% |
Debt/Equity | 0.53 |
RoNW | 30.71% |
PAT Margin | 12.13 |
Price to Book Value | 3.09 |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 5.37 | 4.75 |
P/E (x) | 10.05 | 11.36 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2024 that is available in RHP.
Shanmuga Hospital IPO Objectives
The Objects of the Issue are:
- Funding Capital Expenditure towards Purchase of additional Medical Equipment
- General Corporate Purposes
Shanmuga Hospital IPO Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 2000 | ₹1,08,000 |
Retail (Max) | 1 | 2000 | ₹1,08,000 |
HNI (Min) | 2 | 4,000 | ₹2,16,000 |
Lot Size Calculator |
Shanmuga Hospital IPO Details
IPO Date | February 13, 2025 to February 17, 2025 |
Listing Date | [.] |
Face Value | ₹10 per share |
Price | ₹54 per share |
Lot Size | 2,000 Shares |
Total Issue Size | 38,18,000 shares (aggregating up to ₹20.62 Cr) |
Fresh Issue | 38,18,000 shares (aggregating up to ₹ 20.62 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 97,95,000 shares |
Share Holding Post Issue | 1,36,13,000 shares |
Market Maker Portion | 1,92,000 shares Black Fox Financial Private Limited |
Shanmuga Hospital IPO Company Overview and Services
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital.
Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions.
Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.
Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering IPD and OPD services with a dedicated team.
Hospital Units:
- Shanmuga Pharmacy & Diagnostics:
The hospital operates Shanmuga Pharmacy, providing medications to OPD and IPD patients. Shanmuga Diagnostics offers reliable pathology services for accurate medical evaluations and treatment planning. - Shanmuga Clinics:
The hospital extends services through Shanmuga Clinics, providing specialized consultations and treatments in Salem. Critical patients are transferred to the main hospital for advanced care when necessary.
Services: Oncology, General Surgery, Orthopaedics, Cardiology,General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes Department, Plastic Surgery, Respiratory Medicine.
As on August 31, 2024, the hospital had 72 doctors, out of whom 9 doctors were Resident Doctors, 7 Junior Doctors, 28 Senior Consulting Doctors and 28 Consulting Visiting Doctors.
Competitive Strengths:
- Oncology Presence
- Rich experience of promoters of over four decades
- Cost Affordable to Regional Population
- Specialized Equipment like LINAC, CATHLAB, MRI, MODULAR OT
- Tie-up with Government and Private Insurance Companies
Shanmuga Hospital IPO SWOT Analysis
Strengths:
- Established Reputation: Shanmuga Hospital has a strong reputation as a leading multi-specialty facility in Salem and surrounding regions. This established brand can attract patients and investors alike.
- NABH and NABL Accreditation: Accreditation from NABH (National Accreditation Board for Hospitals & Healthcare Providers) and NABL (National Accreditation Board for Testing and Calibration Laboratories) 1 demonstrates the hospital’s commitment to quality and high standards of healthcare. This can increase patient trust and confidence.
- Comprehensive Services: The hospital offers a wide range of medical services, from preventive care to rehabilitation, covering various specialties. This comprehensive approach caters to diverse healthcare needs and can attract a larger patient base.
- Modern Infrastructure and Technology: Shanmuga Hospital is equipped with cutting-edge healthcare technology and modern infrastructure, including advanced diagnostic facilities and modular operating theaters. This enables the hospital to provide high-quality care and attract skilled medical professionals.
- Experienced Medical Professionals: The hospital has a team of experienced doctors, including senior consultants, visiting doctors, and resident doctors. This expertise ensures quality medical care and can contribute to positive patient outcomes.
Weaknesses:
- Limited Bed Capacity: With a 151-bed capacity, the hospital might face limitations in accommodating a large number of patients, especially during peak seasons or outbreaks. This could restrict revenue growth and expansion potential.
- Regional Focus: The hospital primarily serves patients from Salem and surrounding regions. This regional focus might limit its growth potential compared to hospitals with a wider geographic reach.
- Competition: The healthcare industry is competitive, with the presence of other established hospitals and new entrants. Shanmuga Hospital needs to differentiate itself to attract and retain patients.
- Dependence on Skilled Professionals: The hospital’s operations rely heavily on skilled medical professionals. Any shortage of qualified doctors or staff could impact the quality of care and operational efficiency.
Opportunities:
- Increasing Healthcare Demand: The demand for quality healthcare services is rising due to factors like an aging population, increasing prevalence of chronic diseases, and growing health awareness. This trend presents significant growth opportunities for the hospital.
- Expansion of Services: Shanmuga Hospital can expand its services by introducing new specialties, investing in advanced technology, and offering specialized care programs. This can attract more patients and increase revenue streams.
- Strategic Partnerships: Collaborating with other healthcare providers, insurance companies, or research institutions can help the hospital expand its reach, improve service delivery, and enhance its reputation.
- Focus on Technology and Innovation: Embracing telemedicine, digital health solutions, and data analytics can improve operational efficiency, enhance patient experience, and provide personalized care.
Threats:
- Rising Operating Costs: The healthcare industry faces increasing operating costs due to factors like rising medical equipment costs, increasing salaries for medical professionals, and regulatory compliance expenses. This could impact the hospital’s profitability.
- Regulatory Changes: Changes in healthcare regulations, licensing requirements, or reimbursement policies can create challenges for the hospital and impact its operations.
- Economic Downturn: An economic downturn can affect people’s ability to afford healthcare services, potentially reducing patient volumes and impacting the hospital’s revenue.
- Competition from Larger Players: Larger hospital chains with greater resources and wider networks can pose a threat to Shanmuga Hospital’s growth and market share.
Shanmuga Hospital IPO GMP Details
Shanmuga Hospital SME IPO last GMP is ₹8, last updated Feb 10th 2025 02:53 PM. With the price band of 54.00, Shanmuga Hospital SME IPO’s estimated listing price is ₹62 (cap price + today’s GMP).The expected percentage gain/loss per share is 14.81%.>> Shanmuga Hospital SME IPO Retail Subject to Sauda: ₹12200
We update GMP on a daily basis and based on last 3 sessions grey market activities, today IPO GMP points upward and expects a strong listing. The lowest GMP is ₹0.00, while the highest GMP is ₹8.00. Stay with us to know the daily price trend of Shanmuga Hospital SME IPO GMP with expected listing price.
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Estimated Listing Price | Last Updated |
---|---|---|---|---|---|
10-02-2025 | 54.00 | ₹8 ![]() |
12200 | ₹62 (14.81%) | 10-Feb-2025 14:53 |
09-02-2025 | 54.00 | ₹0 ![]() |
— | ₹54 (0.00%) | 9-Feb-2025 23:32 |
08-02-2025 | 54.00 | ₹0 ![]() |
— | ₹54 (0.00%) | 8-Feb-2025 23:35 |
What is IPO GMP?
The grey market premium (GMP) reflects the unofficial trading price of an IPO before its listing, offering insights into its potential market performance. A positive GMP indicates that the IPO may yield profits, while a negative GMP suggests a possible discount upon listing. However, it’s essential to recognize that IPO GMP can be highly volatile. Therefore, investors should not make decisions solely based on the GMP but should thoroughly assess all relevant factors before investing.
Shanmuga Hospital IPO Subscription Status
Note that the bidding starts at 10 AM and ends at 5 PM on the days when the public issue is open.
Shanmuga Hospital IPO Allotment status
Shanmuga Hospital IPO allotment is expected on Tuesday, February 18, 2025.
Shanmuga Hospital IPO allotment status is not available at this time. Shanmuga Hospital IPO – The allotment status will be available once the basis of allotment is finalized. Please revisit us to check the latest updates for Shanmuga Hospital Limited IPO allotment status.
Shanmuga Hospital IPO Contact Details
Shanmuga Hospital Limited
51/24,
Saradha College Road,
Salem, 636007
Phone: +91 427 2706674
Email: cs@smrft.org
Website: http://www.shanmugahospital.com/
Disclaimer: Investing in Initial Public Offerings (IPOs) involves substantial risk, and financial returns are not guaranteed. The information provided should not be construed as financial or investment advice. Prospective investors are advised to consider their financial situation, investment objectives, and risk tolerance before participating in an IPO. It is recommended to consult with a qualified financial advisor or professional before making any investment decisions. Past performance is not indicative of future results. Investments in IPOs may be subject to market risk, including the potential loss of principal.
Want to Raise money for your company through SME IPO? Read More